Navigation Links
Care Investment Trust Inc. Announces Fourth Quarter and Partial Year 2007 Results
Date:3/11/2008

Fourth Quarter and Year-end Highlights - Transitioned investment focus to an equity REIT strategy and closed on two ventures owning more than $320 million of quality healthcare-related

real estate. - Generated net income in the 2007 fourth quarter of $3.6 million, or $0.17

per basic and diluted share. - Secured a line of credit with Column Financial Inc., an affiliate of Credit Suisse Securities LLC, and borrowed $25 million under the facility

for new investments. - Declared and paid an inaugural dividend of $0.17 per share for the 2007 third quarter and declared a 2007 fourth quarter dividend of $0.17 per

share.

NEW YORK, March 11 /PRNewswire-FirstCall/ -- Care Investment Trust Inc. (NYSE: CRE), a real estate investment and finance company investing in healthcare-related real estate and commercial mortgage debt, today reported financial results for the quarter ended December 31, 2007, and for the period from June 22, 2007 (commencement of operations) to December 31, 2007. Both net income and Funds from Operations (FFO) for the fourth quarter of 2007 were $3.6 million, or $0.17 per basic and diluted share. Adjusted Funds from Operation (AFFO) amounted to $3.8 million, or $0.18 per basic and diluted share. For the period from June 22, 2007 to December 31, 2007, the Company reported a net loss of $1.6 million, or a loss of $0.07 per basic and diluted share. FFO for the partial annual period was a loss of $1.6 million, and AFFO was $7.9 million. AFFO is the result of adding back to net income or loss non-cash stock-based compensation, which amounted to $9.5 million for the partial ann
'/>"/>

SOURCE Care Investment Trust Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
2. Childrens Healthcare of Atlanta Announces Major Investment in Pediatric Research as Part of 10-Year Vision
3. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
4. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
5. Advanced Life Sciences to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference
6. WallSt.net (www.wallst.net) Updates Investment Community Through All-New Interview With digiMedical Solutions
7. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
8. MGT Capital Investments, Inc. Approves Share Buyback Program
9. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
10. WallSt.net Updates Investment Community Through All-New Interview With WiFiMed
11. Newly Published Study Demonstrates Return on Investment for Employee Wellness Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Real Time ... lotion and products, today announced their best-selling lotion is now ... Time Pain Relief is an FDA registered OTC pain relief ... herbal ingredients, such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu ... level of Menthol – only 1.25% – to avoid buildup ...
(Date:5/28/2015)... May 28, 2015 Hexagon Geospatial is ... , a provider of engineering, spatial data and mapping ... analyze thousands of point clouds for urban change assessments ... to 2014, the BHI Spatial Data Division implemented a ... stereo aerial imagery. Collected by a variety of different ...
(Date:5/28/2015)... IL (PRWEB) May 28, 2015 Cancer ... program exhibited improvements in physical activity, fitness and quality ... Irwin of Yale Cancer Center and Jennifer Ligibel, MD, ... Women’s Cancers, Dana Farber Cancer Institute. The findings will ... Clinical Oncology (ASCO) Annual Meeting in Chicago. ...
(Date:5/28/2015)... May 28, 2015 The MIT Sloan ... study featuring Healthcare IQ. Members of the MIT CISR ... management team to develop the case study about Healthcare ... analytics. , The case study, ‘Healthcare IQ: Competing as ... from its beginning as a hospital financial software provider ...
(Date:5/28/2015)... Dallas urologist Mark Allen, MD has ... education website NORTHTEXASUROLOGIST.COM developed by eMedical ... access current educational information on various urological concerns ... prostate cancer treatment, robotic surgery and female urinary ... educate patients on urological conditions and treatments, enabling ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2
... embarks on one of its top priorities--reforming the nation,s health care ... of Health Care Reform, which will be announced during a media ... , ... Washington, DC (Vocus) February 6, 2009 -- As ...
... The Pink Frister on The Pacific Edge is set for ... Lucy, CEO of Code Pink Boot Camp, is pleased to ... event benefiting Fristers, a non-profit that supports teen and young ... 28 at 4:00pm at the Pacific Edge Hotel in Laguna ...
... "Psoriasis Cure Now," a nonprofit patient advocacy organization, ... help everyday Americans interested in medical research be heard ... powerful lobbyists and special interests. The Web site ... make biomedical research a meaningful part of any stimulus ...
... whether people were scanned or not , , FRIDAY, Feb. 6 ... low back pain that has no apparent underlying cause doesn,t ... that doctors should not conduct routine MRI, CT or radiography ... authors say. , Dr. Roger Chou, of the Oregon Health ...
... skepticism correlate with lower cancer screening rates , , FRIDAY, ... women, have more distrust of the medical system, which ... research shows. , Almost half of all women agreed ... health-care organizations." Eighteen percent strongly agreed with the statement. ...
... Institute for Palliative Medicine,s Fellowship Program received full accreditation ... -- the first accredited fellowship program in palliative medicine ... Diego Hospice, The Institute for Palliative Medicine has trained ... Medicine is known as one of the most clinically ...
Cached Medicine News:Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 3Health News:Code Pink Boot Camp Supports Fristers and Young Mothers 2Health News:Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill 2Health News:Imaging of Low Back Pain Fails to Change Outcomes 2Health News:Minorities Distrust Medical System More 2Health News:Minorities Distrust Medical System More 3Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 2Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 3
(Date:5/28/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ... "2015 Strategies in the US Ancillary Hospital Locations ... to their offering. This new 973-page ... of the diagnostic testing markets outside the main ... includes analysis of the market dynamics, size, growth, ...
(Date:5/28/2015)... May 28, 2015  Freedom Meditech, Inc., a medical ... diseases from current blood-based standards to early and non-invasive ... million in a Series C financing. The company seeks ... million since founded. The company has also appointed Mr. ... a member of the company,s board of directors. Mr. ...
(Date:5/28/2015)... , May 28, 2015  According to Kalorama Information, ... Omnicare for approximately $12.7 billion fits a prevailing trend ... from an aging population. The U.S. long term care ... to continue as the aging population increases demand for ... The healthcare market researcher,s report, The Long Term ...
Breaking Medicine Technology:Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
Ice block will provide sufficient cooling for most normal blotting applications. Sealed block is held submerged in transfer buffer. Ice block will not spill during refreezing....
... Downward Transfer Kit High resolution ,transfer of ... Rapid ,Unique downward capillary transfer allows ... neutral ,(SSC) transfers in three hours. , ... less buffer and blotting paper. Convenient refill ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
Medicine Products: